Concurrent Investment Advisors’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.45M Buy
52,634
+1,379
+3% +$111K 0.04% 467
2026
Q1
$3.62M Sell
51,255
-1,239
-2% -$92.8K 0.04% 432
2025
Q4
$4.14M Buy
52,494
+9,005
+21% +$713K 0.05% 373
2025
Q3
$3.58M Buy
43,489
+2,500
+6% +$197K 0.06% 311
2025
Q2
$3.3M Buy
40,989
+52
+0.1% +$4.01K 0.06% 306
2025
Q1
$3.29M Buy
40,937
+10,590
+35% +$881K 0.08% 258
2024
Q4
$2.48M Buy
30,347
+2,139
+8% +$178K 0.07% 279
2024
Q3
$2.33M Buy
28,208
+1,370
+5% +$102K 0.07% 275
2024
Q2
$1.88M Buy
26,838
+21,407
+394% +$1.53M 0.06% 291
2024
Q1
$402K Sell
5,431
-66
-1% -$4.6K 0.02% 607
2023
Q4
$363K Buy
+5,497
New +$344K 0.02% 582

Other funds holding MET

Concurrent Investment Advisors's MET Position: Q2 2026 in Review

Concurrent Investment Advisors increased its MetLife (MET) stake by 2.7% in Q2 2026, buying an estimated $111K and bringing the position to 52,634 shares worth $4.45M. The position accounts for 0.04% of the portfolio, ranked #467.

Concurrent Investment Advisors first reported a position in MET in Q4 2023 and has held it in 11 quarters since. 1,442 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Concurrent Investment Advisors held 52,634 shares of MetLife worth $4.45M as of Q2 2026.
  • Concurrent Investment Advisors bought 1,379 MetLife shares in Q2 2026, an estimated $111K.
  • MetLife made up 0.04% of Concurrent Investment Advisors's portfolio in Q2 2026, its #467 holding.
  • Concurrent Investment Advisors first reported a position in MetLife in Q4 2023 and has held it in 11 quarters since.
  • 1,442 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.